Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of AMED will rise by +3.32% over the next 2 Weeks and hit $104.34 by Friday, August 29, 2025. In that time frame, AMED's share price is expected to range between $103.47 and $105.23.
BearishAverageBullishAMED shares rose +0.01% in Thursday, August 14, 2025's trading session, rising from a previous close of $100.98 to move at $100.99. The stock demonstrated notable intraday movement (see AMED's key stats for a full breakdown), fluctuating between $100.93 and $101.02, a +0.09% trading range. While recent weeks have seen some volatility, AMED has managed to secure a +2.53% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 0 shares changing hands, 1.06M fewer than the previous session. This amounted to $0.00 in total market activity.
Will AMED Continue Its Upward Trend?
According to analyst ratings and projections for AMED, Amedisys, Inc. shares are anticipated to increase by +4.04%, potentially reaching $105.24 per share by August 29, 2025. Short-term technical indicators currently suggest a neutral sentiment for AMED. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the AMED stock forecast, now is a good time to buy AMED stock because its current trading price is -3.21% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on AMED covering social and institutional perspectives.
AMED Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into AMED's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 70.46% to 81.05%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 62.93%, suggests strong medium-term momentum. However, the 100-day RSI, at 57.89%, maintains a neutral outlook for the long term. Insights into AMED's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Amedisys, Inc. Monthly Forecast 2025–2026
August 2025
According to our latest forecast models, Amedisys, Inc. (AMED) is positioned to show a strong performance in August 2025. The price is predicted to move between $84.04 and $93.28, settling at an average of $88.10. This could translate to a -12.76% loss.
September 2025
Based on current market signals, Amedisys, Inc. is projected to trend september 2025. We forecast a trading range from $81.95 to $94.54, with a likely average price of $87.83. Investors could expect a potential return of -13.03%.
October 2025
Our predictive algorithms indicate Amedisys, Inc. stock may see a shift in October 2025. The expected range spans $83.98–$94.08, with an average target of $89.08. This represents a cautious outlook and a possible loss of -11.79%.
November 2025
Analyzing established trends, Amedisys, Inc. looks set to move in November 2025. Projections place the stock between $85.91 and $96.14, averaging around $91.01. This suggests a -9.88% loss from current levels.
December 2025
Market indicators suggest Amedisys, Inc. could experience notable changes during December 2025. Prices could fluctuate within $88.25 to $96.91, with a midpoint forecast of $92.86. The stock might deliver a -8.05% loss.
January 2026
Forecasting for January 2026, models estimate that Amedisys, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $82.75 and $96.92, averaging $89.39. This signals a cautious trajectory with potential returns around -11.49%.
February 2026
According to our latest forecast models, Amedisys, Inc. (AMED) is positioned to show a strong performance in February 2026. The price is predicted to move between $81.21 and $93.22, settling at an average of $86.98. This could translate to a -13.87% loss.
March 2026
Based on current market signals, Amedisys, Inc. is projected to trend march 2026. We forecast a trading range from $83.15 to $93.24, with a likely average price of $88.15. Investors could expect a potential return of -12.71%.
April 2026
Our predictive algorithms indicate Amedisys, Inc. stock may see a shift in April 2026. The expected range spans $85.64–$95.34, with an average target of $90.20. This represents a cautious outlook and a possible loss of -10.68%.
May 2026
Analyzing established trends, Amedisys, Inc. looks set to move in May 2026. Projections place the stock between $87.32 and $96.84, averaging around $91.91. This suggests a -8.99% loss from current levels.
June 2026
Market indicators suggest Amedisys, Inc. could experience notable changes during June 2026. Prices could fluctuate within $81.80 to $96.37, with a midpoint forecast of $88.47. The stock might deliver a -12.40% loss.
July 2026
Forecasting for July 2026, models estimate that Amedisys, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $80.00 and $92.22, averaging $86.05. This signals a cautious trajectory with potential returns around -14.79%.
August 2026
According to our latest forecast models, Amedisys, Inc. (AMED) is positioned to show a strong performance in August 2026. The price is predicted to move between $82.43 and $91.13, settling at an average of $86.72. This could translate to a -14.13% loss.
AMED's history of dividends and stock splits also plays a role in long-term investor confidence.